Health In Tech (NASDAQ:HIT – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.01, Zacks reports. The business had revenue of $8.77 million during the quarter.
Here are the key takeaways from Health In Tech’s conference call:
- Health In Tech reaffirmed full-year 2026 revenue guidance of $45 million to $50 million, implying roughly 35% to 50% year-over-year growth as the company continues to invest in expansion.
- First-quarter revenue was $8.8 million, up about 9% from last year, but adjusted EBITDA turned negative $1.3 million as spending increased on sales, marketing, and product development.
- The company introduced new reporting metrics: contracted revenue of about $22.9 million for the rest of 2026 and platform placed plan value of $82 million in Q1, which management said gives better visibility into future revenue.
- Management is stepping up investment in distribution, carrier partnerships, and AI-enabled technology, including a new AWS-related development effort and a more proactive broker go-to-market strategy.
- The company highlighted strong early interest in its three-year rate stabilization program and said it is on track for market testing later in 2Q into 3Q 2026, with no upfront deposit required from customers.
Health In Tech Price Performance
Health In Tech stock traded up $0.02 during midday trading on Wednesday, hitting $1.54. 148,631 shares of the stock were exchanged, compared to its average volume of 280,551. Health In Tech has a 1 year low of $0.56 and a 1 year high of $4.02. The firm has a market cap of $92.34 million, a P/E ratio of 77.00 and a beta of 3.67. The company has a 50 day moving average price of $1.59 and a two-hundred day moving average price of $1.56.
Institutional Investors Weigh In On Health In Tech
Analyst Ratings Changes
Several research firms have recently commented on HIT. Craig Hallum began coverage on shares of Health In Tech in a research report on Monday, April 20th. They issued a “buy” rating and a $4.00 price target on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of Health In Tech in a research report on Thursday, April 2nd. Finally, Wall Street Zen lowered shares of Health In Tech from a “hold” rating to a “sell” rating in a research report on Saturday, April 25th. Two investment analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $3.25.
View Our Latest Research Report on Health In Tech
About Health In Tech
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Read More
- Five stocks we like better than Health In Tech
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
